Skip Navigation

The University of Texas Southwestern

Location

The University of Texas Southwestern
Southwestern Medical Center at Dallas
2201 Inwood Rd
Suite NC2.130
Dallas, TX 75390-8562
Direct phone: (214) 645-HOPE (4673)
Toll-free: (866) 460-HOPE (4673)

Total transplants by cell source

From January 1, 2017 to December 31st, 2018
  • Marrow: 5
  • PBSC: 54
  • Cord Blood: 0
  • Autologous (PBSC or Marrow): 145
Performs adult transplants

Overview

The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwesterns Harold C. Simmons Comprehensive Cancer Center is one of the nations leading programs for hematologic malignancies. With a focus on excellence and compassion, our physicians and staff manage patients at all stages of their care. The program has an excellent track record in the delivery of state-of-the-art transplants. In addition, the program features an active translational research component that aims to improve transplant results by applying recent advances in immunobiology to the clinic.

This center has been performing allogeneic transplants since 1999 and has been an NMDP/Be The Match transplant center since December 2001.

Attending physicians

Adult - Larry Anderson, Farrukh l Awan, Stephen Chung, Robert Collins, Ankit Kansagra , Yazan Madanat, Prati Patel, Praveen Ramakrishnan, Syed Rizvi, Madhuri Vusirikala

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on

Adult only

Other programs and services

As part of the only National Cancer Institute-designated Comprehensive Cancer Center in North Texas, The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwestern Medical Center is able to offer referring physicians and patients a range of services unsurpassed in the region, including:
 Diagnosis and treatment of all hematologic malignancies
 Stem cell transplantation - autologous, allogeneic related and unrelated, cord blood, haploidentical)
 Investigational therapy
 Specialized center for acute myeloid leukemia and myelodysplastic syndrome, plasma cell neoplasms (multiple myeloma, Waldenstroms macroglobulinemia, and amyloidosis), chronic lymphocytic leukemia, and acute lymphoblastic leukemia
 Familial malignancies clinic
 Cutaneous T-cell lymphoma clinic
 CNS lymphoma clinic
 Chronic GVHD (graft-versus-host disease) clinic
 Survivorship clinic
 Comprehensive second opinion service
 Nationally renowned hematopathology (microscopy, flow cytometry, cytogenetics, molecular diagnostics)
 In-depth genetic and functional screening of patients with relapsed/refractory malignancies, allowing for individualized molecular-targeted therapy

Extensive Clinical Trials
Blood and Marrow Transplantation patients at UT Southwestern and Simmons Cancer Center have access to the latest advances and treatments through our clinical trials program, which typically includes 30 or more phase I-III clinical trials at any time.

CAR T-cell Therapy
UTSW has a very active program in CAR T-cells, for standard-of-care indications  including certain types of diffuse large B-cell lymphoma and acute lymphoblastic leukemia  as well as experimental indications, including multiple myeloma and several other B-cell malignancy subtypes.

Multidisciplinary Treatment Teams
Highly integrated and coordinated multidisciplinary teams provide optimal, state-of-the-art care. Teams are composed of physicians who specialize solely in hematologic malignancies, oncology-certified nurses and transitional coordinators, advance

About the center

Overview

The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwesterns Harold C. Simmons Comprehensive Cancer Center is one of the nations leading programs for hematologic malignancies. With a focus on excellence and compassion, our physicians and staff manage patients at all stages of their care. The program has an excellent track record in the delivery of state-of-the-art transplants. In addition, the program features an active translational research component that aims to improve transplant results by applying recent advances in immunobiology to the clinic.

This center has been performing allogeneic transplants since 1999 and has been an NMDP/Be The Match transplant center since December 2001.

Attending physicians

Adult - Larry Anderson, Farrukh l Awan, Stephen Chung, Robert Collins, Ankit Kansagra , Yazan Madanat, Prati Patel, Praveen Ramakrishnan, Syed Rizvi, Madhuri Vusirikala

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on

Adult only

Other programs and services

As part of the only National Cancer Institute-designated Comprehensive Cancer Center in North Texas, The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwestern Medical Center is able to offer referring physicians and patients a range of services unsurpassed in the region, including:
 Diagnosis and treatment of all hematologic malignancies
 Stem cell transplantation - autologous, allogeneic related and unrelated, cord blood, haploidentical)
 Investigational therapy
 Specialized center for acute myeloid leukemia and myelodysplastic syndrome, plasma cell neoplasms (multiple myeloma, Waldenstroms macroglobulinemia, and amyloidosis), chronic lymphocytic leukemia, and acute lymphoblastic leukemia
 Familial malignancies clinic
 Cutaneous T-cell lymphoma clinic
 CNS lymphoma clinic
 Chronic GVHD (graft-versus-host disease) clinic
 Survivorship clinic
 Comprehensive second opinion service
 Nationally renowned hematopathology (microscopy, flow cytometry, cytogenetics, molecular diagnostics)
 In-depth genetic and functional screening of patients with relapsed/refractory malignancies, allowing for individualized molecular-targeted therapy

Extensive Clinical Trials
Blood and Marrow Transplantation patients at UT Southwestern and Simmons Cancer Center have access to the latest advances and treatments through our clinical trials program, which typically includes 30 or more phase I-III clinical trials at any time.

CAR T-cell Therapy
UTSW has a very active program in CAR T-cells, for standard-of-care indications  including certain types of diffuse large B-cell lymphoma and acute lymphoblastic leukemia  as well as experimental indications, including multiple myeloma and several other B-cell malignancy subtypes.

Multidisciplinary Treatment Teams
Highly integrated and coordinated multidisciplinary teams provide optimal, state-of-the-art care. Teams are composed of physicians who specialize solely in hematologic malignancies, oncology-certified nurses and transitional coordinators, advance

Overall center survival


Patient survival information for this center

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2015, 2016, 2017, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 81 patients.

The actual 1-year survival of these patients is 75.3%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 65.6% and 83.6%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

Total transplants

Total transplants


204

Transplants reported (From January 1, 2017 to December 31st, 2018 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 0 24 0 24
Unrelated donor 5 30 0 35
Total allogeneic 5 54 0 59
Autologous
Both marrow & PBSC
145
-- 145
Total combined
204 0 204

Transplants by disease

All diseases

Number of transplants by age reported from January 1, 2017 to December 31st, 2018 (includes marrow, PBSC and cord blood)

0-18 19-44 45-64 65+ Total
Related 0 5 16 3 24
Unrelated 0 11 20 4 35
Autologous 1 26 82 36 145
Total 1 42 118 43 204

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants for this disease can be found:

Additional information

Transplant center resources

If you have transplant-related questions, please call the transplant center's direct phone number.

If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.

Be The Match patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743

Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

Survivorship program

Loading survivorship program information...